Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Names Nano Gen Teknolojileri as Turkish Distributor

NEW YORK (GenomeWeb News) – Fluidigm said today that it has named Nano Gen Teknolojileri as its exclusive distributor for its genetic analysis products in Turkey.

Specifically, Nano Gen Teknolojileri will distribute Fluidigm's BioMark system for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection, and absolute quantification; as well as its EP1 System for high-throughput SNP genotyping and end-point digital PCR research, Fluidigm said.

"Fluidigm is committed to bringing the benefits of increased sensitivity, accuracy, and reduced costs of integrated fluidic circuit technology to life science researchers in Turkey," Dominique Remy-Renou, European vice president of sales for Fluidigm, said in a statement. "This partnership with Nano Gen Teknolojileri brings our technology and products along with Nano Gen's reputation of first-rate customer support to Turkish scientists."

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.